Kevin C Tang - Net Worth and Insider Trading

Kevin C Tang Net Worth

The estimated net worth of Kevin C Tang is at least $240.3 Billion dollars as of 2024-04-28. Kevin C Tang is the CEO, 10% Owner of Odonate Inc and owns about 12,767,435 shares of Odonate Inc (ODTCD) stock worth over $240.2 Billion. Kevin C Tang is the Director, 10% Owner of La Jolla Pharmaceutical Co and owns about 9,607,934 shares of La Jolla Pharmaceutical Co (LJPC) stock worth over $60 Million. Kevin C Tang is also the Director of Heron Therapeutics Inc and owns about 5,821,098 shares of Heron Therapeutics Inc (HRTX) stock worth over $14 Million. Besides these, Kevin C Tang also holds Vanda Pharmaceuticals Inc (VNDA) , Jounce Therapeutics Inc (JNCE) , TCR2 Therapeutics Inc (TCRR) , Rain Oncology Inc (RAIN) , Assertio Holdings Inc (ASRT) , Aradigm Corp (ARDMQ) , Cyclacel Pharmaceuticals Inc (CYCC) , Aptevo Therapeutics Inc (APVO) . Details can be seen in Kevin C Tang's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Kevin C Tang has not made any transactions after 2023-12-18 and currently still holds the listed stock(s).

Transaction Summary of Kevin C Tang

To

Kevin C Tang Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kevin C Tang owns 12 companies in total, including Odonate Inc (ODTCD) , La Jolla Pharmaceutical Co (LJPC) , and Heron Therapeutics Inc (HRTX) among others .

Click here to see the complete history of Kevin C Tang’s form 4 insider trades.

Insider Ownership Summary of Kevin C Tang

Ticker Comapny Transaction Date Type of Owner
ODTCD Odonate Inc 2021-11-19 director & 10 percent owner & Chief Executive Officer
LJPC La Jolla Pharmaceutical Co 2022-08-22 director & 10 percent owner
HRTX Heron Therapeutics Inc 2019-10-04 10 percent owner
CYCC Cyclacel Pharmaceuticals Inc 2017-02-23 10 percent owner
MRTX Mirati Therapeutics Inc 2013-09-19 10 percent owner
VNDA Vanda Pharmaceuticals Inc 2010-01-14 10 percent owner
ARDMQ Aradigm Corp 2008-10-21 10 percent owner
MTEM Molecular Templates Inc 2006-08-11 10 percent owner
APVO Aptevo Therapeutics Inc 2021-11-23 10 percent owner
JNCE Jounce Therapeutics Inc 2023-03-14 10 percent owner
TCRR TCR2 Therapeutics Inc 2023-05-25 10 percent owner
RAIN Rain Oncology Inc 2023-12-18 10 percent owner

Kevin C Tang Latest Holdings Summary

Kevin C Tang currently owns a total of 11 stocks. Among these stocks, Kevin C Tang owns 12,767,435 shares of Odonate Inc (ODTCD) as of November 19, 2021, with a value of $240.2 Billion and a weighting of 99.95%. Kevin C Tang owns 9,607,934 shares of La Jolla Pharmaceutical Co (LJPC) as of December 1, 2021, with a value of $60 Million and a weighting of 0.02%. Kevin C Tang also owns 5,821,098 shares of Heron Therapeutics Inc (HRTX) as of October 4, 2019, with a value of $14 Million and a weighting of 0.01%. The other 8 stocks Vanda Pharmaceuticals Inc (VNDA) , Jounce Therapeutics Inc (JNCE) , TCR2 Therapeutics Inc (TCRR) , Rain Oncology Inc (RAIN) , Assertio Holdings Inc (ASRT) , Aradigm Corp (ARDMQ) , Cyclacel Pharmaceuticals Inc (CYCC) , Aptevo Therapeutics Inc (APVO) have a combined weighting of 0.01% among all his current holdings.

Latest Holdings of Kevin C Tang

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ODTCD Odonate Inc 2021-11-19 12,767,435 18,810.00 240,155,452,350
LJPC La Jolla Pharmaceutical Co 2021-12-01 9,607,934 6.22 59,761,349
HRTX Heron Therapeutics Inc 2019-10-04 5,821,098 2.45 14,261,690
VNDA Vanda Pharmaceuticals Inc 2010-01-14 2,715,852 4.62 12,547,236
JNCE Jounce Therapeutics Inc 2023-03-14 5,300,087 1.88 9,964,164
TCRR TCR2 Therapeutics Inc 2023-05-25 4,394,800 1.48 6,504,304
RAIN Rain Oncology Inc 2023-12-18 3,850,513 1.21 4,659,121
ASRT Assertio Holdings Inc 2008-01-18 954,400 0.83 790,434
ARDMQ Aradigm Corp 2007-01-25 146,250 0.05 6,728
CYCC Cyclacel Pharmaceuticals Inc 2017-02-23 1,866 1.51 2,818
APVO Aptevo Therapeutics Inc 2021-11-23 0 0.71 0

Holding Weightings of Kevin C Tang


Kevin C Tang Form 4 Trading Tracker

According to the SEC Form 4 filings, Kevin C Tang has made a total of 8 transactions in Odonate Inc (ODTCD) over the past 5 years, including 7 buys and 1 sells. The most-recent trade in Odonate Inc is the sale of 2,747,131 shares on November 19, 2021, which brought Kevin C Tang around $6 Million.

According to the SEC Form 4 filings, Kevin C Tang has made a total of 7 transactions in La Jolla Pharmaceutical Co (LJPC) over the past 5 years, including 6 buys and 1 sells. The most-recent trade in La Jolla Pharmaceutical Co is the sale of 441,290 shares on December 1, 2021, which brought Kevin C Tang around $2 Million.

According to the SEC Form 4 filings, Kevin C Tang has made a total of 1 transactions in Heron Therapeutics Inc (HRTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Heron Therapeutics Inc is the acquisition of 285,714 shares on October 4, 2019, which cost Kevin C Tang around $5 Million.

More details on Kevin C Tang's insider transactions can be found in the Insider Trading History of Kevin C Tang table.

Insider Trading History of Kevin C Tang

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kevin C Tang Trading Performance

GuruFocus tracks the stock performance after each of Kevin C Tang's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kevin C Tang is 3.26%. GuruFocus also compares Kevin C Tang's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kevin C Tang within 3 months outperforms 35 times out of 63 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Kevin C Tang's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Kevin C Tang

Average Return

131.88%

Average return per transaction

Outperforming Transactions

54%

33 out of 61 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 3.14 3.26 49.95 131.88 6.08 -21.85
Relative Return to S&P 500(%) 4 3.61 46.28 120.53 -4.91 -34.42

Kevin C Tang Ownership Network

Ownership Network List of Kevin C Tang

No Data

Ownership Network Relation of Kevin C Tang


Kevin C Tang Owned Company Details

What does Odonate Inc do?

Who are the key executives at Odonate Inc?

Kevin C Tang is the director & 10 percent owner & Chief Executive Officer of Odonate Inc. Other key executives at Odonate Inc include 10 percent owner Ecor1 Capital, Llc , director & 10 percent owner Boxer Capital, Llc , and director & 10 percent owner Aaron I. Davis .

Odonate Inc (ODTCD) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Odonate Inc (ODTCD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Odonate Inc (ODTCD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Odonate Inc (ODTCD)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Odonate Inc Insider Transactions

No Available Data

Kevin C Tang Mailing Address

Above is the net worth, insider trading, and ownership report for Kevin C Tang. You might contact Kevin C Tang via mailing address: 4747 Executive Drive, Suite 210, San Diego Ca 92121.

Discussions on Kevin C Tang

No discussions yet.